What do experts say about Glutathione?

Julia Solnier et al.: "The LipoMicel micellar formulation produced significantly higher baseline-adjusted systemic glutathione exposure than standard glutathione despite a lower administered dose."

← All supplements

Supplement

Glutathione

Q: Is Glutathione worth taking?

We grade Glutathione C- for worth-it at a typical cost of $20-50 per month. Liposomal glutathione is expensive relative to thin outcome evidence. A NAC plus glycine stack costs far less and raises glutathione through the body's own synthesis; direct glutathione is worth considering mainly when precursors are not tolerated.

The body's master antioxidant, but poorly absorbed as a plain pill.

Glutathione is the cell's main internal antioxidant, made from glycine, cysteine, and glutamate, used for detoxification and redox balance. We grade Glutathione C on evidence and C- for worth-it at about $20-50 per month.

Evidence

C-

Worth it

Typical cost: $20-50/month

What it does

Glutathione is the cell's main internal antioxidant, made from glycine, cysteine, and glutamate, used for detoxification and redox balance. Plain oral glutathione is largely broken down in the gut, which is why most research tests liposomal forms or its precursors instead.

What the research says

Raises blood and cellular glutathione with liposomal or micellar delivery
Evidence: moderate. A 2025 randomized crossover trial found a micellar (LipoMicel) formulation gave about 2.5x higher systemic exposure than standard glutathione at a lower dose; a 2026 study reported about 6x higher peak levels with a liposomal form.
Reduces oxidative stress markers in deficient populations
Evidence: emerging. Small studies in diabetes, liver disease, and aging report improved redox and immune markers, but clinical-outcome trials are sparse.
Precursors (NAC plus glycine) raise glutathione reliably
Evidence: moderate. NAC supplies rate-limiting cysteine; combined NAC and glycine supplementation in older adults raised glutathione and improved several aging biomarkers in a small RCT.

The core problem is pharmacokinetic: plain oral glutathione has poor bioavailability, and newer liposomal and micellar products improve blood exposure, not proven clinical outcomes. Human outcome trials are small and short; the precursor route (NAC plus glycine) has comparable or better support at lower cost.

What the experts say

Every position links to its source. We include skeptics alongside supporters.

Julia Solnier et al.
“The LipoMicel micellar formulation produced significantly higher baseline-adjusted systemic glutathione exposure than standard glutathione despite a lower administered dose.”
Source, 2026-04-01 Authors of the 2025 randomized crossover bioavailability trial; concluded delivery-enhanced formulations increase systemic exposure while preserving redox control, and that larger long-term studies are still needed.

Is it worth it?

C-

Liposomal glutathione is expensive relative to thin outcome evidence. A NAC plus glycine stack costs far less and raises glutathione through the body's own synthesis; direct glutathione is worth considering mainly when precursors are not tolerated.

Typical cost

$20-50/month

Common form, not a brand recommendation

Dosage contextemerging

Studies used 250-1000 mg/day of liposomal or reduced glutathione; the precursor alternative is about 600 mg NAC plus 1-2 g glycine daily. No outcome-validated longevity dose exists.

Safety notes

Oral glutathione is generally well tolerated. Note that inhaled and IV forms carry real risks (bronchospasm, reactions) and are medical procedures, not supplements. NAC can cause GI upset and interacts with nitroglycerin and some blood-pressure drugs. Supplement quality varies; look for third-party testing.

Longevity Lab Report

Glutathione news, graded when it happens.

New studies, dose debates, and expert shifts on glutathione, in one email a week. Free.

Changelog

Last updated 2026-10-15

2026-10-15|Batch 2 DRAFT entry.